Floatz logo

njh395

NON-breast HER2+ Malignancies

Novartis PharmaceuticalsPhase 1
Rating in progress

njh395 in NON-breast HER2+ Malignancies is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant